Posts

Surrey expert recognized on International Women in Engi...

The Women’s Engineering Society has named the University of Surrey’s Dr Kelly Ko...

Mystery of how leaf-cutting ants gauge leaf portion siz...

They might not be able to leap tall buildings with a single bound, but leaf-cutt...

New rapid viral plaque detection system, aided by deep ...

Findings Credit: Ozcan Lab Findings In a new paper published in Nature Biomedica...

More exposure needed for cosmetic breast enhancement risks

Complications after cosmetic breast augmentation are more common than other cosm...

Combination therapy effective against canine melanoma

A combination of radiotherapy followed by immunotherapy is a promising strategy ...

COVID-19’s impact on socioeconomic inequality in health...

Key Findings Credit: KYAN Akira and TAKAKURA Minoru Key Findings This study is t...

Should You Take Probiotics For Vaginal Health?

When you hear about probiotics, you likely mostly think of gut health, digestion...

FDA rejects F2G’s NDA for new antifungal drug, Olorofim

The Food and Drug Administration (FDA) in the U.S. has rejected the U.K.-based F...

FDA Gives Green Light to Agepha Pharma’s Heart Disease ...

Colchicine was first used as a treatment for inflammation in Egypt more than 350...

AstraZeneca Ditches GLP-1 Drug After Phase 1 Setback, C...

AstraZeneca’s decision to abandon its remaining clinical candidate, AZD0186, mar...

Teikoku Pharma bags FDA fast track for post-surgical tr...

The company’s transdermal system delivers dexmedetomidine over four days to help...

FDA grants access to new class of paediatric diabetes m...

Two decades after its approval of metformin, the FDA approves a new class of ora...

CSL doses first patient with haemophilia B gene therapy...

America’s most expensive gene therapy, Hemgenix eliminates the need for prophyla...

AGEPHA Pharma’s LODOCO gets US FDA approval for cardiov...

LODOCO can be utilised as a monotherapy or in combination with cholesterol-lower...

Coya Therapeutics expands COYA 301 patent estate

COYA 301 is designed to improve Treg function in vivo to treat underlying autoim...

US FDA approves Pfizer’s Talzenna with Xtandi for prost...

The FDA approval was based on the findings obtained from the Phase III TALAPRO-2...